SYNOPSIS The aggregating effects of adenosine diphosphate, thrombin, 5-hydroxytryptamine, tryptamine, adrenaline and noradrenaline, and tri-ethyl tin have been carefully compared. The first three compounds in some circumstances produce remarkably similar effects although there are important differences. The kinetics of aggregation induced by adrenaline (and noradrenaline) are quite different and the tri-ethyl tin effects are different again. Anti-serotonins specifically inhibit 5-hydroxytryptamine and the anti-adrenaline drug phentolamine specifically inhibits the effects of the catecholamines.
It has now been reported that platelet aggregation can be brought about by thrombin, adenosine diphosphate (Gaarder, Jonsen, Laland, Hellem, and Owren, 1961), tri-ethyl tin (O'Brien, 1963a) , and by noradrenaline and 5-hydroxytryptamine (Mitchell and Sharp, 1964) . It is not known what forces and mechanisms are involved in platelet-to-platelet adhesion, although it has been shown that thrombin liberates the diphosphate (Grette, 1962) and it has been suggested that tri-ethyl tin may liberate disphosphate which thus might form a final common pathway (O'Brien, 1963b (200, 763, 1963) and in two lectures which are in the press: 'The International Committee for the Nomenclature of Blood Clotting Factors' (Thromb. et Diath. Haem.) and 'The Proceedings of the IX Congress of the European Society of Haematology', S. Karger.
Received for publication 3 October 1963. 4 u. per ml.) human platelet-rich plasma containing about 400,000 platelets per c.mm. was kept at 15°C. and was normally warmed to 37°C. for five minutes before use. Each pool was used within six hours of collection. Two millilitres were placed in a cuvette, and stirred at a constant optimal speed by a magnetic stirrer. The cuvette, kept at 37°C. was put in an EEL titrometer (a photocolorimeter) and the light transmission through the cloudy suspension was recorded in arbitrary units on a Honeywell recorder (O'Brien, 1962) . A similar method has been carefully evaluated by Born and Cross (1963b) . Thus a second by second record of the degree of dispersion of the platelets was obtained. Normally, the plasma was stirred for a sufficient period to ensure that no spontaneous aggregation would occur, and then sufficient aggregating compound dissolved in 0-1 ml. of barbitonebuffered saline was added to give the final concentrations mentioned in the text. The magnitude of the response of different batches of plasma to the same dose of an aggregating agent, and especially to inhibitors, differed somewhat, so each set of comparisons had to be carried out on the same day and the slightly differing results of different days were averaged.
Usually five different compounds, always including saline as a control, were injected in differing orders down the arm. With a sphygomanometer cuff inflated on the upper arm to 40 mm. Hg (Borchgrevink, 1960) cuts 0-8 cm. long were made across the injection sites, and the bleeding times were estimated. RESULTS TIME PATTERN OF AGGREGATION AND DOSE RESPONSE These are described for each substance.
Adenosine diphosphate Increasing concentrations of this diphosphate were added to aliquots of the same platelet-rich plasma and Fig. 1 records a typical family of curves. It will be seen that aggregation begins at once and that with increasing concentrations the initial slope increased indicating more rapid aggregation. The initial slopes of these curves, which are almost linear, are proportional to the log of the dose of diphosphate added. With low concentrations, but over at least a five-fold range, aggregation stops after about 40 seconds, the inactivation time, then disaggregation occurs. The added diphosphate must have been inactivated or is no longer available since it can be shown that these platelets at this time will reaggregate if a further dose of diphosphate is added. Since the inactivation time is the same when the added diphosphate concentration is increased from 3M x 10-8 to M x 10-7 it can be concluded that higher concentrations are inactivated considerably faster. A further important consequence of the roughly constant time taken to inactivate varying concentrations of diphosphate is that the maximum degree of aggregation observed for any particular dose is proportional to the initial slope and hence it is also proportional to the original dose. Thus to characterize the effect of any given dose it is, in practice, more convenient to measure the total change in transmission than the initial slope.
The approximate concentrations required to produce minimal and maximal aggregation (both poorly defined criteria) for adenosine diphosphate and other compounds is given in Table I . The effect of adding a second equal dose of diphosphate and other compounds after the platelets have disaggregated or reached a plateau after a first dose, is given in Table IlI and illustrated in Figure 2 . Thrombin Only a small range of thrombin concentrations could be studied because with high concentrations rapid clotting interfered with aggregation. It is shown in Fig. 2 Aggregation 3-5M x 10-7 l5M x 10-6 l 5M x 10-6 SM x 10-6 l5M x 10-3 0-066 units/ml. 3M x 10-7 SM x 10-8 5M x 10-6 2-5M x 10-' 2-5M x 10-8 15M x 10-7 5M x 1O-9 5Mx 1O-7 5M x 10-6 2M x 1O-7 5M xl0-' 1-5M x 10-5 M x 10-' (E) M x 1O-4 5Mx 1O-7 5M x 1O-7 5M x 1O-7 7-5M x 10-4 (S) 1-6M x 1O-7 5M x 10-6 5M x 10-'Inhibition as defined in the text was caused by the inhibitors at the strengths shown. For tri-ethyl tin the strength of an inhibitor needed to prolong the lag phase is given; A.T.P. at the given strengths enhanced (E) the effect of adrenaline and shortened (S) the lag phase of tri-ethyl tin. When high concentrations of the inhibitors had no effect on aggregation, the relevant space is left blank.
A.D.P. The following experiment showed that when adrenaline causes platelet aggregation adenosine diphosphate is liberated. This might suggest that the release of diphosphate is responsible for aggregation induced by adrenaline. Adrenaline was added to 2-5 ml. stirred platelet-rich plasma to give a final concentration of 5M x 10-and the mixture stirred till final complete aggregation was observed. This mixture was then rapidly centrifuged and 0 5 ml. of the supernatant was then added to another aliquot of platelet-rich plasma to which phentolamine, final concentration 5M x 10-6, had previously been added. Marked aggregation immediately occurred. It could be inhibited by strong adenosine and the curve obtained was identical to that obtained with adenosine diphosphate. Adrenaline was added to platelet-poor plasma and treated identically; 0-5 ml. of this mixture was added to the platelet-rich plasma-phentolamine mixture and no aggregation occurred. The platelet-rich plasma was frozen and thawed twice and 0O5 ml. of the supernatant after centrifugation was added to a phentolamine plateletrich plasma mixture. The resulting aggregation was less than that obtained from the adrenaline-treated platelets. This last observation is compatible with the suggestion that adrenaline brings about the conversion of intrinsic adenosine triphosphate in the platelet to diphosphate.
The following experiment shows that treated platelets that will not aggregate when diphosphate is added will still respond normally to adrenaline. Thus adrenaline-induced aggregation may not be caused by the liberation of diphosphate. Diphosphate, 0-1 ml. of 5M x 103, was added at the same time to each of three cuvettes containing 2 ml. of citrated platelet-rich plasma. The first was stirred at once and showed immediate gross aggregation (Fig. 4) . The second cuvette was not stirred till 60 minutes later when slight aggregation only was recorded. The third cuvette stirred after 90 minutes' stationary incubation showed no aggregation. Then a further 0.1 ml. of diphosphate was added and the stirring continued. Since no aggregation occurred, this confirmed that the platelets were almost completely unresponsive to the extrinsic diphosphate. Strong adrenaline was then added and gave a normal response. It was also shown that platelets incubated but not stirred with adrenaline finally became nonsticky. If diphosphate was then added, normal aggregation occurred (Fig. 5) . These two experiments show that platelets incubated with either adrenaline or diphosphate lose their stickiness even though an excess of the compound is present, and that such platelets are still capable of becoming sticky again when the other compound is added. Thus, the production of stickiness by each of these compounds may be a different and independent process.
To test the effect of the inhibitors in vitro of aggregation on phenomena in vivo some compounds were injected intradermally and bleeding times carried out on the injection sites. The results are summarized in Table IV Hovig (1963) has shown that collagen also causes the release of diphosphate. There is no evidence whether or not 5-hydroxytryptamine liberates diphosphate although it is known that triphosphate is involved in its uptake into the platelet (Born, Ingram, and Stacey, 1958) . Thus it appears that following all additions which cause aggregation, diphosphate is liberated. Added diphosphate itself causes aggregation and adenosine and the monophosphate inhibit the effects of added diphosphate (Born and Cross, 1963a; O'Brien, 1963c) and of adrenaline etc. Therefore, it is possible that diphosphate is the final common cause of aggregation if such exists as already suggested by Clayton and Cross (1963) . (Hovig, 1963) . That the effects of adrenaline and 5-hydroxytryptamine are mediated through specific receptor sites is emphasized by the specific inhibition of each by the anti-adrenaline drug phentolamine and by the anti-serotonins Ro 3/0837 and UML 491 respectively. Mitchell and Sharp (1964) (Born, Ingram, and Stacey, 1958; Sano, Kakimoto, and Taniguchi, 1958) and adrenaline (Born, Hornykiewicz, and Stafford, 1958) (Aldridge, 1958 cat, the effect in vitro on platelet aggregation, and the effect in vivo on the bleeding time, which presumably reflects an effect on aggregation in vivo (Table V) . Accordingly adrenaline may have some common basic mechanism in these three different biological situations. adrenaline, noradrenaline, 5-hydroxytryptamine, thrombin, collagen, and tri-ethyl tin might be due to the stimulation of an adenosine triphosphatase. This tentative suggestion is represented diagrammatically in Figure 6 . The formation of, or the presence of added, diphosphate might equally be the final common cause of aggregation but this seems less likely in view of the experiments summarized in Figures 4 and 5. The effects of the specific anti-adrenaline and anti-serotonin inhibitors, of adenosine, the mono-and tri-phosphates, and of the non-specific inhibitors like cocaine (antiadhesive compounds) are compatible with either hypothesis. The observation that an anti-adrenaline compound prolongs the bleeding time suggests but does not prove that adrenaline (or noradrenaline) plays a part in haemostasis, and if so, it would seem reasonable to suggest that adrenaline causes platelet aggregation and/or increased stickiness to the damaged vessel wall. This suggestion gains support from the observation that another anti-adrenaline compound, dibenyline, does not (except at high concentration) block adrenaline-induced aggregation in vitro and it does not prolong the bleeding time. It is of interest that Derouaux (1941) showed that adrenaline in some circumstances shortens the bleeding time in rabbits and that Ozge, Mustard, Hegardt, Rowsell, and Downie (1963) claim that adrenaline shortens the platelet half life in pigs.
There is a remarkable similarity in the response of three catecholamines and two inhibitors of adrenaline in three situations, namely, the stimulation of smooth muscle of the nictitating membrane of the
